Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 w » 5 wt (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
w decrease » we decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 w » 5 wt (Expand Search)
-
1341
-
1342
Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D.
Published 2013“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”
-
1343
-
1344
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. …”
-
1345
SPL decreases diabetes-induced oxidative stress in GL and PT.
Published 2017“…Similar results were found between CTL and SPL groups. Data are mean±SEM from 5–6 rats per group. *p<0.05; **p<0.01 and ***p<0.001.…”
-
1346
-
1347
-
1348
-
1349
-
1350
PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues.
Published 2013“…One unit means a decrease in OD<sub>620</sub> per second. …”
-
1351
-
1352
The expression of genes related to mitochondria was decreased in Pgam2 mice.
Published 2013“…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
-
1353
-
1354
-
1355
-
1356
-
1357
-
1358
-
1359
-
1360
Acute JMV2959 treatment decreases alcohol preference in rats.
Published 2013“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”